José Alberto Ayala Ortiz to participate in the AEFI Symposium 2023

  • Post published:June 1, 2023

We are happy to announce that José Alberto Ayala Ortiz, PVpharm's CEO will be participating in one session of the 2023 Pharmacovigilance symposium organized by AEFI. During the session, José will be talking about safety in food or food supplements. Please take a look to the program at this link: https://www.aefi2023.com/

Continue ReadingJosé Alberto Ayala Ortiz to participate in the AEFI Symposium 2023

Is the Local Medical Literature Search in Pharmacovigilance really an obligation?

  • Post published:January 19, 2022

It is well known that the medical literature is a significant source of information for the monitoring of the safety profile and of the risk-benefit balance of medicinal products. However, we may have doubts about whether it is really mandatory or not. And indeed, yes, it is an obligation. The European Medicines Agency confirms this in the Good Pharmacovigilance Practices (GVP) Module VI: "The marketing authorisation holder should ensure that the literature review includes the use of reference databases that contain the largest reference of articles in relation to the medicinal product properties." "In addition, marketing authorisation holders should have procedures…

Continue ReadingIs the Local Medical Literature Search in Pharmacovigilance really an obligation?